← FDA DRUG APPROVALS

FDA ANDA · ANDA070269

ALLOPURINOL

Sponsor: SANDOZ

APPLICATION
ANDA070269
TYPE
ANDA
ORIGINAL APPROVAL
1985-12-31
LATEST ACTION
2024-12-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ALLOPURINOLDiscontinued
ALLOPURINOL 300MG · TABLET · ORAL

Approval history

2024-12-11Labeling · Supplement 19 · standardAP
2001-05-09Manufacturing (CMC) · Supplement 15AP
1999-03-04Manufacturing (CMC) · Supplement 14AP
1994-12-20Manufacturing (CMC) · Supplement 13AP
1988-01-26Manufacturing (CMC) · Supplement 10AP
1988-01-26Manufacturing (CMC) · Supplement 11AP
1987-07-15Manufacturing (CMC) · Supplement 9AP
1987-07-15Manufacturing (CMC) · Supplement 5AP
1987-05-08Manufacturing (CMC) · Supplement 4AP
1986-08-27Manufacturing (CMC) · Supplement 2AP
1986-03-11Manufacturing (CMC) · Supplement 1AP
1985-12-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →